Title : Impact of obesity on safety outcomes and treatment modifications with ado-trastuzumab emtansine in breast cancer patients.

Pub. Date : 2022 Jan

PMID : 33356991






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 INTRODUCTION: Ado-trastuzumab emtansine (T-DM1) is an antibody-drug conjugate indicated for the treatment of HER2-positive breast cancer. Maytansine erb-b2 receptor tyrosine kinase 2 Homo sapiens